A Randomised Pilot Study to Evaluate the Effect(s) of Casodex 150 mg and Zoladex 3.6 mg on Pathological and Genomic Tumour Markers in Subjects Undergoing Radical Prostatectomy for Localised Prostate Carcinoma
Interventional
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Proliferation by Ki67,
Teuvo L Tammela, Professor
Principal Investigator
Tampere University Central Hospital
Finland: Finnish Medicines Agency
D6876C00001
NCT00293696
October 2004
November 2006
Name | Location |
---|